BDBM675864 3-((2S)-3-(8-(4-ethyl-3,4-dihydro-2H-benzo[b][1,4]oxazin-6-ylsulfonyl)-1-oxa-8-azaspiro[4.5]decan-3-ylamino)-2-hydroxypropoxy)-N-methylbenzenesulfonamide::US11987588, Compound 333

SMILES CCN1CCOc2ccc(cc12)S(=O)(=O)N1CCC2(CC(CO2)NC[C@H](O)COc2cccc(c2)S(=O)(=O)NC)CC1

InChI Key InChIKey=FVQRQWWAFMCQMW-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 675864   

TargetBeta-3 adrenergic receptor(Human)
Arena Pharmaceuticals

US Patent
LigandPNGBDBM675864(US11987588, Compound 333 | 3-((2S)-3-(8-(4-ethyl-3...)
Affinity DataIC50: 9.02nMAssay Description:HTRF cAMP assays were performed according to manufacturer's instructions (Cisbio, cAMP Dynamic 2 Assay Kit; #62AM4PEJ). CHO-K1 cells stably expre...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2024
Entry Details
Go to US Patent